Promoter hypomethylation of SKI in autoimmune pancreatitis
Promoter hypomethylation of SKI in autoimmune pancreatitis
复制标题
DOI:
10.1016/j.prp.2018.03.005
复制
发表时间:
2018-04-01
影响因子:
2.8
通讯作者:
Ota, Hiroyoshi
中科院分区:
文献类型:
--
作者:
Kinugawa, Yasuhiro;Uehara, Takeshi;Ota, Hiroyoshi
The relationship between methylation abnormality and autoimmune pancreatitis (AIP) a representative IgG4related disease has not yet been elucidated. We identified SKI might have a significant methylation abnormality in AIP through methylation array analysis using the Illumine Infinium Human Methylation 450K BeadChip array, and investigated the relationship of SKI with AIP clinicopathological features. The methylation rate of SKI was assessed by quantitative SYBR green methylation-specific PCR, and the degree of SIG expression in tissue specimens was assessed by immtmohistochemistry in 10 AIP cases, 14 cases of obstructive pancreatitis area in pancreatic ductal adenocarcinoma (PDA) without a history of ALP, and 9 normal pancreas (NP) cases. The SKI methylation ratio was significantly lower in AIP than in PDA and NP. Additionally, the inununohistochemical staining-index (SI) score for SKI was significantly higher in AIP than NP, although there was no significant difference between AIP and PDA. There was a strong negative correlation between SI score and SIG methylation ratio, and between the serum concentrations of IgG4 and the SKI methylation ratio. There was a moderate positive correlation between the serum concentrations of IgG4 and SI. SKI is thought to be an oncogene indicating that SKI hypomethylation and carcinogenesis might be linked to MP. Furthermore, the correlation between serum concentrations of IgG4 and SKI methylation levels suggest SKI might be involved in the pathogenesis of AIP. However, the role of SIG has not been clearly elucidated. Further studies are needed to understand further the function of SKI.